免疫监测和逃避中的衰老癌细胞:机制和治疗影响
Dechang Liu1, Jia Wang1, Yuancheng Wei1
1New Drug Screening and Pharmacodynamics Evaluation Center, China Pharmaceutical University, Nanjing, 210009, China.
Journal of leukocyte biology
|September 2, 2025
概括
细胞衰老是一种不可逆转的细胞循环停止状态, 在癌症免疫中起着双重作用. 衰老的癌细胞可以促进或抑制抗瘤免疫反应,影响癌症的进展.
科学领域:
- 癌症学
- 免疫学
- 细胞生物学
背景情况:
- 细胞衰老是一种压力诱导的状态,其特征是细胞循环停止和生物活性分子 (SASP) 的分泌.
- 衰老的癌细胞可以通过调节免疫反应来影响瘤的微环境.
- 在促进抗瘤免疫与免疫抑制方面,SnCs的双重作用需要详细了解.
研究的目的:
- 审查免疫系统识别和消除SnCs的机制.
- 探索SNC如何在TME中逃避免疫监视.
- 讨论针对SNCs的新型癌症治疗策略.
主要方法:
- 关于细胞衰老和癌症免疫学的文献综述.
- 通过SNCs对免疫识别和逃避机制的分析.
- 探索治疗策略,包括基于SnC的疫苗和组合疗法.
主要成果:
- 免疫系统使用三个主要机制来识别和消除SnCs.
- 在TME中,SNC利用了三种不同的策略来逃避免疫监视.
- 新兴的治疗方法利用SnC治疗癌症.
结论:
- 了解SnC与免疫相互作用对于癌症治疗的发展至关重要.
- 针对SnCs提供了增强抗瘤免疫力的潜力.
- 新的策略如基于SnC的疫苗和组合疗法显示出有前途.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
Replicative Cell Senescence
3.7K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.7K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659


